NICE signals commitment to greater flexibility in its evaluation of promising new health technologies and making patient access fairer


20 January 2022 - Changes to the way medicines and other health technologies are evaluated by NICE for use in the NHS were approved by its Board yesterday (19 January 2022).

The changes will come into effect early next month for new evaluations and will give patients earlier access to innovative new treatments by allowing greater flexibility over decisions about value for money and consideration of a broader evidence base.

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder